These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10518243)

  • 1. Design and evaluation of a new transdermal formulation containing chlorpheniramine maleate.
    Ceschel GC; Maffei P; Gentile M
    Drug Dev Ind Pharm; 1999 Sep; 25(9):1035-9. PubMed ID: 10518243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and ex vivo permeation studies of chlorpheniramine maleate gels prepared by carbomer derivatives.
    Taş C; Ozkan Y; Savaşer A; Baykara T
    Drug Dev Ind Pharm; 2004 Jul; 30(6):637-47. PubMed ID: 15285337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives.
    Tas C; Ozkan Y; Savaser A; Baykara T
    Farmaco; 2003 Aug; 58(8):605-11. PubMed ID: 12875891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and stability study of chlorpheniramine maleate nasal gel.
    Soliman II; Soliman NA; Abdou EM
    Pharm Dev Technol; 2010; 15(5):484-91. PubMed ID: 20735301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of transdermal chlorpheniramine maleate drug delivery system.
    Andronis V; Mesiha MS; Plakogiannis FM
    Pharm Acta Helv; 1995 Dec; 70(4):301-6. PubMed ID: 8765696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipient in buccal tablets.
    Alur HH; Pather SI; Mitra AK; Johnston TP
    Int J Pharm; 1999 Oct; 188(1):1-10. PubMed ID: 10528077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses.
    Kuroda T; Nagata S; Takizawa Y; Tamura N; Kusano K; Mizobe F; Hariu K
    Vet J; 2013 Aug; 197(2):433-7. PubMed ID: 23489843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal administration of emedastine.
    Harada S; Takahashi Y; Nakagawa H
    Biol Pharm Bull; 1993 Sep; 16(9):884-8. PubMed ID: 7903575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transbuccal delivery of chlorpheniramine maleate from mucoadhesive buccal patches.
    Sekhar KC; Naidu KV; Vishnu YV; Gannu R; Kishan V; Rao YM
    Drug Deliv; 2008; 15(3):185-91. PubMed ID: 18379931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro permeation screening of a new formulation of thiocolchicoside containing various enhancers.
    Ceschel GC; Maffei P; Porzio S; Melillo G; Caselli GF; Dragani MC; Gentile MM; Clavenna G
    Drug Deliv; 2002; 9(4):259-63. PubMed ID: 12511205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of Methocel K15M bioadhesive matrix tablets.
    Chary RB; Rao YM
    Drug Dev Ind Pharm; 2000 Aug; 26(8):901-6. PubMed ID: 10900549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical properties and mechanisms of drug release from melt-extruded granules consisting of chlorpheniramine maleate and Eudragit FS.
    Zhang F
    Drug Dev Ind Pharm; 2016; 42(4):563-71. PubMed ID: 26065535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid identification and quantification of chlorpheniramine maleate or pheniramine maleate in pharmaceutical preparations by thin-layer chromatography-densitometry.
    Subramaniyan SP; Das SK
    J AOAC Int; 2004; 87(6):1319-22. PubMed ID: 15675442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput screening of transdermal formulations.
    Karande P; Mitragotri S
    Pharm Res; 2002 May; 19(5):655-60. PubMed ID: 12069169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecific versus nonstereospecific assessments for the bioequivalence of two formulations of racemic chlorpheniramine.
    Bui TH; Fernandez C; Vu K; Nguyen KH; Thuillier A; Farinotti R; Arnaud P; Gimenez F
    Chirality; 2000 Aug; 12(8):599-605. PubMed ID: 10897096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation Development and Characterization of Nanoemulsion-Based Formulation for Topical Delivery of Heparinoid.
    Bakshi P; Jiang Y; Nakata T; Akaki J; Matsuoka N; Banga AK
    J Pharm Sci; 2018 Nov; 107(11):2883-2890. PubMed ID: 30055224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid simultaneous determination of paracetamol, amantadine hydrochloride, caffeine and chlorpheniramine maleate in human plasma by liquid chromatography/tandem mass spectrometry.
    Feng S; Tian Y; Zhang Z; Zhang J; Huang M; Chen Y
    Arzneimittelforschung; 2009; 59(2):86-95. PubMed ID: 19338139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate.
    Varshosaz J; Pardakhty A; Baharanchi SM
    Drug Deliv; 2005; 12(2):75-82. PubMed ID: 15824032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations.
    Mojaverian P; Radwanski E; Lin CC; Cho P; Vadino WA; Rosen JM
    Pharm Res; 1992 Apr; 9(4):450-6. PubMed ID: 1495888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.